Sleep Apnea in Paralympic Ontario-Resident aThletes With Spinal Cord Injury (SPORTS) Study
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Dec 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SPORTS study is looking at how effective a treatment called continuous positive airway pressure (CPAP) is for athletes with spinal cord injuries who have sleep-related breathing problems, like sleep apnea. This trial aims to see if using CPAP can help improve thinking skills, reduce feelings of tiredness, depression, and anxiety, and enhance overall quality of life for these para-athletes. Additionally, the study will investigate whether this treatment can improve their sports performance and help them feel safer during activities.
To join this study, participants need to be adults aged 18 or older with a cervical or thoracic spinal cord injury that has lasted for more than six months and must play a wheelchair sport at a high-performance level. Those who have previously been diagnosed with sleep apnea or have certain other health conditions may not be eligible. Participants will receive CPAP therapy and will be monitored for improvements in their health and sports performance throughout the study. This is a great opportunity for eligible athletes to contribute to important research that could benefit others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with a cervical or thoracic, complete or incomplete (AIS A to D), chronic (\> 6 months) SCI;
- • English-speaking adults (18 years of age or older); and
- • Play a wheelchair sport at a high-performance level.
- Exclusion Criteria:
- • A previous history of diagnosis and treatment for sleep apnea;
- • Concomitant diseases of the central nervous system and other pre-existing diseases of the central nervous system;
- • Current substance misuse;
- • History of primary hypersomnia, or secondary hypersomnia of any cause except for SRBDs.
- • Conditions that might prevent participants to follow the study protocol.
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Dr. Julio Furlan
Principal Investigator
University Health Network, Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported